Drug intelligence / Profile preview

Botanical Tincture

Development stage: Unknown
Lead developer: Stamford Hospital
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

A botanical formulation delivered as a tincture, currently being evaluated by Stamford Hospital in a randomized pilot trial for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C). The study focuses on its feasibility and efficacy in reducing abdominal pain and improving stool frequency in patients diagnosed using Rome IV criteria. As a botanical extract, it likely contains a blend of phytochemicals intended to modulate gastrointestinal motility and visceral sensitivity, though the specific herbal components are not publicly detailed in the primary trial registration (NCT04141410).

Other names: Botanical Tincture

Beyond the preview

Go deeper on Botanical Tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botanical Tincture.

Explore the full profile